Evgeny Kobin

Evgeny Kobin Email and Phone Number

Pharmaceutical Marketing | Pipeline Commercialization | Launch Strategy | Brand Development | Rare Diseases | Oncology @ Telix Pharmaceuticals Limited
Evgeny Kobin's Location
Basking Ridge, New Jersey, United States, United States
Evgeny Kobin's Contact Details
About Evgeny Kobin

Biopharmaceutical Marketing professional with 20+ years of diverse experience in brand strategy, new product commercialization, and product portfolio management in oncology and rare diseases. MD and MBA, specializing in short-term and long-term planning and market strategy to achieve organizational goals and business objectives. Product Marketing | Product Planning | Head of Marketing | Pipeline CommercializationEmail: Evgeny.Kobin@gmail.comLeads global launch plan development, coordinating all milestones, ensuring successful commercial launch, and market approvals, adhering to guidelines and regulatory laws. Strong project management skills across cross-functional teams, providing strategic leadership and accountability for teams’ critical success. Drives innovative ideas in support of product portfolio, tracking product performance, and communicating status updates to senior leadership. Collaborates with teams for supply planning and business deliverables. Communicates effectively, managing internal and external stakeholder expectations. Passion for bringing new treatments to patients in need. CORE COMPETENCIES: • Biotech & Pharmaceutical Commercial Marketing • Brand Strategy & Planning• New Product Launch • Market Research & Analysis• Product Performance & KPIs• Cross-Functional Team Management• Stakeholder Relationship Management• Rare Diseases• Oncology & NeurologyACCOMPLISHMENTS:~ Led global strategy evolution for $365M rare disease brand with oversight for tactical plan development and pull through with 20% year over year revenue growth~ Aligned large cross-functional matrix organizations and built global product strategy and launch roadmaps for six brands~ Managed geographical prioritization and expansions for $2.5B Factor VIII product portfolio resulting in 20% annual business growth

Evgeny Kobin's Current Company Details
Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited

View
Pharmaceutical Marketing | Pipeline Commercialization | Launch Strategy | Brand Development | Rare Diseases | Oncology
Evgeny Kobin Work Experience Details
  • Telix Pharmaceuticals Limited
    Global Commercial Lead Tlx250Tx
    Telix Pharmaceuticals Limited 2024 - Present
    North Melbourne, Victoria, Au
  • Telix Pharmaceuticals Limited
    Head Of Global Commercialization Tlx250Cdx
    Telix Pharmaceuticals Limited 2023 - 2024
    North Melbourne, Victoria, Au
  • Amicus Therapeutics
    Global Brand Leader, Galafold
    Amicus Therapeutics 2019 - 2022
    Princeton , Nj, Us
    Led global brand strategy refinement and oversaw tactical plan development and its pull through supporting $365M brand with 20% year over year revenue growthIntroduced global annual cross-functional brand planning and budgeting process and led alignment with US and International commercial teams on key marketing tactics
  • Eli Lilly And Company
    Launch Lead, Cyramza, Urothelial Carcinoma (Uc)
    Eli Lilly And Company 2016 - 2018
    Indianapolis, Indiana, Us
    Built global strategy and US/EU/JP launch roadmaps for Cyramza in bladder cancer in highly competitive and dynamic market environment with 5 competing immuno-therapy products approved
  • Materia Medica
    New Product Planning Lead
    Materia Medica 2013 - 2016
    Developed commercial strategy for $500M biosimilar product portfolio in oncology, hematology and immunology
  • Baxter International Inc.
    Global Marketing Director, Hemophilia Product Portfolio And Geographic Expansions
    Baxter International Inc. 2011 - 2013
    Deerfield, Illinois, Us
    Led geo prioritization and expansion for $2.5B Factor VIII portfolio of 4 brands resulting in 20% business growthIntroduced and managed Global Hemophilia Tender Council process, which helped secure 5 strategic FVIII tenders
  • Novartis Oncology
    Launch Lead, Afinitor, Tuberous Sclerosis Complex (Tsc)
    Novartis Oncology 2010 - 2011
    Basel, Switzerland, Ch
    Aligned US and global cross-functional teams on brand positioning, strategic imperatives and key tactics to support launch with non-oncology target customer base (pediatric neurologists)Built disease awareness campaign
  • Novartis Oncology
    Associate Marketing Director, Afinitor, Lcm
    Novartis Oncology 2007 - 2010
    Basel, Switzerland, Ch
    Led commercial strategy, forecasting and brand planning for 9 emerging indications in DLBC and Mantle Cell lymphomas, Breast and Gastric Cancers, Tuberous Sclerosis Complex and Hepatocellular Carcinoma representing over $1B in projected peak salesLaunched branding around clinical development program (www.thewideprogram.com) to ensure the most efficient patient enrollment rate across pivotal trials
  • Abraxis Bioscience
    Sr Manager, Global Brand Strategy, Abraxane
    Abraxis Bioscience 2006 - 2007
    Los Angeles, Ca, Us
    Built global brand launch strategy in breast cancerDeveloped market access strategy, pricing assumptions and budget impact models for 5 key European marketsFully operationalized global Named Patient Program
  • Pfizer
    Sales And Marketing - Anti-Infectives
    Pfizer 1995 - 2000
    New York, New York, Us

Evgeny Kobin Skills

Oncology Global Marketing Pharmaceutical Sales Biotechnology Pharmaceutical Industry Strategy Market Access Clinical Development Hospital Sales Marketing Neurology Commercialization Leadership Hematology Market Development Management Pharmaceutics Product Launch Health Economics Clinical Research Clinical Trials Medical Affairs Healthcare Competitive Intelligence Therapeutic Areas Dermatology Plannning Urology Lifesciences Sales Effectiveness Cardiology Segmentation Diabetes Infectious Diseases Pharmaceutical Sales And Marketing Global Strategic Marketing Global Pharmaceutical Launch Planning And Implementation Medical Marketing And Market Development Oncology Marketing

Evgeny Kobin Education Details

  • Northwestern University - Kellogg School Of Management
    Northwestern University - Kellogg School Of Management
    Master Of Business Administration - Mba
  • First Moscow State Medical University Named After I.M. Sechenov
    First Moscow State Medical University Named After I.M. Sechenov
    Doctor Of Medicine - Md
  • Financial University Under Government Of Russian Federation
    Financial University Under Government Of Russian Federation
    International Economics

Frequently Asked Questions about Evgeny Kobin

What company does Evgeny Kobin work for?

Evgeny Kobin works for Telix Pharmaceuticals Limited

What is Evgeny Kobin's role at the current company?

Evgeny Kobin's current role is Pharmaceutical Marketing | Pipeline Commercialization | Launch Strategy | Brand Development | Rare Diseases | Oncology.

What is Evgeny Kobin's email address?

Evgeny Kobin's email address is ek****@****srx.com

What schools did Evgeny Kobin attend?

Evgeny Kobin attended Northwestern University - Kellogg School Of Management, First Moscow State Medical University Named After I.m. Sechenov, Financial University Under Government Of Russian Federation.

What skills is Evgeny Kobin known for?

Evgeny Kobin has skills like Oncology, Global Marketing, Pharmaceutical Sales, Biotechnology, Pharmaceutical Industry, Strategy, Market Access, Clinical Development, Hospital Sales, Marketing, Neurology, Commercialization.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.